Deepa Prasad - 15 Jun 2021 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
15 Jun 2021
Transactions value $
$0
Form type
4
Filing time
16 Jun 2021, 17:21:59 UTC
Next filing
21 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DSGN Stock Option (right to buy) Award $0 +30K $0.00 30K 15 Jun 2021 Common Stock 30K $27.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in equal monthly installments over a three year period following June 15, 2021 (the "Grant Date") such that the option is fully vested on the third anniversary of the Grant Date.